TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Biofokus
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
22,039
|
19,113
|
19,687 |
Financial expenses |
3
|
0
|
1 |
Earnings before taxes |
1,931
|
957
|
1,871 |
Total assets |
28,374
|
24,870
|
25,413 |
Current assets |
28,169
|
24,677
|
25,378 |
Current liabilities |
8,285
|
6,240
|
7,573 |
Equity capital |
20,089
|
18,630
|
17,840 |
- share capital |
50
![]() |
50
![]() |
50 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
70.8%
|
74.9%
|
70.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
8.8%
|
5.0%
|
9.5% |
Return on assets (ROA) |
6.8%
|
3.8%
|
7.4% |
Current ratio |
340.0%
|
395.5%
|
335.1% |
Return on equity (ROE) |
9.6%
|
5.1%
|
10.5% |
Change turnover |
2,926
|
-574
|
-799 |
Change turnover % |
15%
|
-3%
|
-4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.